Fig. 3

Comparison of clinical, pathological and prognosis between patients with or without crescents. a–f According to ISN/RPS 2018 pathological classification, the AI and CI of renal tissue were evaluated, and the histological classification were classified, to compare the pathological manifestations between patients with or without crescents; g–i: comparison of the main treatment regimens in the first 24 months of follow-up between patients with or without crescents; j estimated marginal means of eGFR (y-axis) for the non-crescents group and crescents group across timepoints (x-axis). Error bars indicate standard error; k comparison of prognosis between patients with or without crescents (Kaplan–Meier curve), p = 0.011 (log-rank test), the end points is eGFR 30% decrease of the baseline or reaching end-stage renal disease or need for dialysis or renal transplantation or death. AI, activity NIH index, CI, chronicity NIH index, Pulse methylprednisolone pulse; CTX cyclophosphamide, eGFR estimated glomerular filtration rate